FDA approves first drug to target the root cause of sickle cell disease
Global Blood Therapeutics receives approval for Oxbryta, making it the first approved drug product that targets the root cause of sickle cell disease.
Archives for December 2, 2019
Headlands Research acquires six trial sites to aid ‘underserved’ populations
Headlands Research builds out its portfolio of sites across the US and Canada and states that it is not finished, with plans to acquire further sites.
Veeva explains rationale for moving deeper into services
Veeva Systems explains reason for moving deeper into services through the acquisition of Physicians World.
Icon braces for BMS-Celgene merger to slow RFP activity
Icon prepares for slowdown in request for proposal (RFP) activity, as BMS and Celgene merge.
Boehringer Ingelheim taps NiceLabel to improve label management
Boehringer Ingelheim adopts a label management system developed by NiceLabel, replacing manual quality control procedures with digital technology.